TY  - ADVS
AU  - Sim,Edith
TI  - Arylamine N-acetyltransferases: part 3 of 3 
T2  - Drug metabolizing enzymes : fundamentals, study methods, recent advances and clinical significance,
PY  - 2016///
CY  - London
PB  - Henry Stewart Talks
KW  - Antibacterial agents
KW  - Biochemical markers
KW  - Breast
KW  - Cancer
KW  - Drug development
KW  - Drugs
KW  - Metabolism
KW  - Enzyme Inhibitors
KW  - Isoenzymes
KW  - Transferases
KW  - Antitubercular Agents
KW  - Arylamine N-Acetyltransferase
KW  - antagonists & inhibitors
KW  - genetics
KW  - metabolism
KW  - Bacterial Infections
KW  - drug therapy
KW  - Biomarkers
KW  - Breast Neoplasms
KW  - diagnosis
KW  - Drug Discovery
KW  - methods
KW  - pharmacology
KW  - Ethnic Groups
KW  - Gene Expression Regulation, Enzymologic
KW  - Genetic Association Studies
KW  - Mice, Transgenic
KW  - Mycobacterium
KW  - drug effects
KW  - Pharmaceutical Preparations
KW  - Pharmacogenetics
N1  - Animated audio-visual presentation with synchronized narration; Title from title frames; Updated version of a talk first published in 2007; Contents: Mechanism of action -- Reaction substrates -- Isoform substrate profiles -- Isoenzymes NAT1 and NAT2 -- Regulation of gene expression -- Pharmacogenetics -- Phenotype/genotype correlation -- Ethnic variation -- Transgenic mouse models -- NAT protein structures -- NAT as a biomarker in breast cancer -- NAT inhibitors as diagnostic agents -- NAT in mycobacteria -- NAT inhibitors as an approach to potential anti-tubercular agents; Access restricted to subscribers
UR  - https://hstalks.com/bs/3320/
UR  - https://hstalks.com/bs/p/16/
ER  -